...
首页> 外文期刊>Journal of Drug Delivery and Therapeutics >Formulation and Evaluation of Pseudoephedrine Hydrochloride Loaded Alginate Microbeads
【24h】

Formulation and Evaluation of Pseudoephedrine Hydrochloride Loaded Alginate Microbeads

机译:盐酸盐盐型藻酸盐微珠的制剂和评价

获取原文

摘要

Multiple unit dosage forms such as microbeads have increased acceptance because of added even spreading of the drug in the gastrointestinal tract, unvarying drug absorption, abridged local irritation and removal of undesirable intestinal retaining of polymeric material, when compared to non-disintegrating single unit dosage form. The purpose of the presented research is to develop microbeads of pseudoephedrine hydrochloride utilizing sodium alginate as the hydrophilic carrier in combination with HPMC as drug release modifier to lessen the dosing frequency and thereby advance the patient compliance. The microbeads were formulated by varying concentrations of HPMC and calcium chloride. The optimum formulation was chosen based upon in vitro drug release studies and further evaluated. The compatibility of drug-polymer was studied using FTIR analysis. The prepared formulation underwent evaluation for various parameters like drug entrapment, microbeads size, swelling index, mucoadhesive property and stability. No significant drug-polymer interactions were observed in compatibility studies and the formulation was found to be stable on 45 days storage. The formulations exhibited an extended drug release pattern which was the ultimate aim of the study. The microbeads represented good yield, high drug entrapment, low microbeads size and appropriate swelling property. The in vitro wash-off test indicated that the sodium alginate microbeads represent decent mucoadhesive properties. Henceforth, the formulated HPMC coated sodium alginate beads can be utilized as a substitute and cost-effective carrier for the oral controlled delivery of pseudoephedrine hydrochloride.
机译:多种单位剂型,如微珠的接受增加,因为与非崩解单位剂型相比,甚至在胃肠道中添加了甚至蔓延,均匀的药物甚至蔓延,均匀的药物吸收,局部刺激,局部刺激的不希望的肠道保留。本研究的目的是利用藻酸钠作为亲水载体的伪麻黄碱的微珠与HPMC作为药物释放改性剂,以减少给药频率,从而推进患者的顺应性。通过不同浓度的HPMC和氯化钙配制微珠。基于体外药物释放研究选择最佳制剂并进一步评估。使用FTIR分析研究了药物 - 聚合物的相容性。制备的配方对药物夹带等各种参数进行评估,微珠尺寸,溶胀指数,粘膜粘附性和稳定性等各种参数。在相容性研究中没有观察到显着的药物 - 聚合物相互作用,并且发现制剂在45天储存时是稳定的。制剂表现出扩展的药物释放模式,这是该研究的最终目的。微珠代表了良好的产量,高药物夹带,低微珠尺寸和适当的溶胀性。体外洗涤试验表明,海藻酸钠微珠代表了体面的粘膜粘附性。此后,配方的HPMC涂覆的海藻酸钠珠粒可作为替代和经济高效的载体用于口服对照盐酸伪盐酸锰进行。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号